The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; none of the 30 sources its claims cite is checked for support yet.
Differential Release of β-Amyloid from Dendrite- Versus Axon-Targeted APP
Open accessAbstract
The β-amyloid precursor protein (APP) plays a central role in the pathogenesis of Alzheimer's disease. APP is processed in neurons, but little is known about the relative contributions of presynaptic or postsynaptic compartments to the release of Aβ peptides. To address this issue, we transduced primary neurons from Sprague-Dawley rats or APP−/−mice (B6.129S7-App tm1Dbo/J) with lentiviral constructs expressing APP chimeras harboring targeting motifs from low-density lipoprotein receptor or neuron-glia cell-adhesion molecule to polarize expression to either dendritic or axonal membranes, respectively. Using imaging and quantitative biochemical approaches, we now report that APP selectively targeted to either axons or dendrites leads to the secretion of full-length Aβ peptides with significantly elevated release from dendritic compartments. These findings reveal that the enzymatic machinery required for production of Aβ peptides are operative both in presynaptic and postsynaptic compartments of primary neurons, leading to the suggestion that Aβ-mediated impairments in glutamatergic neurotransmission is the result of Aβ release from both local and distal neuronal compartments.
Overview
CoChat Summary
TL;DR
DeBoer et al. used lentiviral APP chimeras targeted to dendrites or axons in primary hippocampal neurons and found that Aβ is released from both compartments, with elevated release from dendritically targeted APP. They also report that neuronal APP is processed mainly by β- and γ-secretases to full-length Aβ species, with Aβ1-40 as the principal secreted peptide and little detectable Aβ17-40/p3.
Key findings
- APP chimeras were strongly polarized: surface APP-LDLR had axon–dendrite ratios of 0.25 ± 0.04 in rat neurons and 0.19 ± 0.03 in APP−/− mouse neurons, with >80% at the dendritic surface; APP-NgCAM had ratios of 1.95 ± 0.28 and 1.89 ± 0.34, with ~80% at the axonal surface.
- Aβ was released from both axonal and dendritic compartments, but dendritic APP-LDLR produced more 1-n Aβ than axonal APP-NgCAM or APPΔCterm: APP-LDLR secreted 130.2 ± 15% (p = 0.07 vs APP), APP-NgCAM 61.3 ± 12% (p < 0.01), and APPΔCterm 64.4 ± 11% (p < 0.01) relative to APP. sAPPβ was significantly lower for APP-NgCAM (40.9%, p < 0.05) and APPΔCterm (62.1%, p < 0.05) versus APP.
- The principal secreted Aβ species was Aβ1-40; human APP produced mainly Aβ1-40, whereas endogenous rat APP produced mainly Aβ11-40. Aβ17-40/p3 was nearly undetectable despite detectable sAPPα and α-CTF, suggesting inefficient neuronal α-CTF processing by γ-secretase.
- Native surface APP was preferentially axonal (axon–dendrite ratio 1.84 ± 0.28), while intracellular APP was less polarized (1.20 ± 0.12); the M596V/K612V cleavage mutant showed a distribution indistinguishable from native APP.
Methods
- Primary hippocampal neuron cultures from E18 Sprague-Dawley rats or E17 APP−/− mice (B6.129S7-Apptm1Dbo/J) were transduced at 7 DIV with lentiviral constructs expressing myc-tagged human APP-695 or APP chimeras: APP-LDLR (dendritic targeting), APP-NgCAM (axonal targeting), APPΔCterm, and versions with M596V/K612V mutations.
- Imaging/immunocytochemistry used live P2-1 surface staining, permeabilized myc-1/MAP2 staining, and copGFP fills; axons and dendrites were traced to quantify axon–dendrite ratios and axonal/dendritic fractions.
- Conditioned media were analyzed by 35S-methionine metabolic labeling (10 min synthetic rate, 4 h steady-state), immunoprecipitation with 4G8, 6E10, 2G3, or myc-1, Western blotting with 26D6 or 192-WT, and MALDI-TOF mass spectrometry; statistics used unpaired t tests with unequal variance and p < 0.05.
Limitations
- Stated: the studies examine APP distribution at steady state, so the authors cannot draw conclusions about the trafficking itinerary of the chimeras; live-cell imaging is needed.
- Stated: it is unclear whether differences in secreted Aβ reflect relative steady-state distribution and/or BACE1 activity; dynamic imaging and neo-epitope-specific antibodies are needed. The authors also note that secreted p3 could be degraded by proteases in conditioned media, though they favor inefficient α-CTF processing.
- Evident from the text: findings rely on in vitro primary neuron cultures with lentiviral overexpression of chimeric APP constructs, so they may not fully reflect native APP trafficking/processing in vivo; the APP-LDLR increase versus APP was p = 0.07, not below the stated p < 0.05 threshold, and mass spectrometry profiles are semiquantitative.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
0 Valid · 0 Not valid · 19 Not checked · 84 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Surface staining using the human APP-specific mAb P2-1 revealed that APP-LDLR is primarily localized to the dendritic domain (Fig. 6B, mouse; F, rat).”
§ Neurobiology of Disease Differential Release of -Amyloid from Dendrite-Versus Axon-Targeted APP > APP-LDLR and APP-NgCAM are highly polarized to dendrites or axons, respectively
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These studies revealed that human APP is preferentially polarized to the axonal surface, with an axondendrite ratio of 1.84 Ϯ 0.28 (see Fig. 3B).”
§ Neurobiology of Disease Differential Release of -Amyloid from Dendrite-Versus Axon-Targeted APP > Polarized distribution of APP in primary hippocampal neuron cultures
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We now document that neither endogenous rodent APP nor exogenous human APP are processed by ␣then ␥-secretases to generate p3 (A17-40), but rather are processed by and ␥-secretases to generate full-length A and an array of A peptide-related species.”
§ Neurobiology of Disease Differential Release of -Amyloid from Dendrite-Versus Axon-Targeted APP > Introduction
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These surface polarization indices revealed similar results compared with the native APP chimeras that lack mutations at the ␣and -secretase sites.”
§ Neurobiology of Disease Differential Release of -Amyloid from Dendrite-Versus Axon-Targeted APP > APP-LDLR and APP-NgCAM are highly polarized to dendrites or axons, respectively
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We now document that neither endogenous rodent APP nor exogenous human APP are processed by ␣then ␥-secretases to generate p3 (A17-40), but rather are processed by and ␥-secretases to generate full-length A and an array of A peptide-related species.”
§ Neurobiology of Disease Differential Release of -Amyloid from Dendrite-Versus Axon-Targeted APP > Introduction
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims
Create a free account to see all 103 claims and to verify the 28 references still open.
- It may state two separate claims as one. 25
- Probably not a substantial claim. 14
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“exogenously expressed human APP695 has been detected on both axonal and dendritic surfaces in primary rodent neurons”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [82]
In the citing paper
“In primary rat hippocampal neurons, a chimeric APP with a LDLR cytoplasmic tail was artificially targeted to dendrites, which resulted in an increase in Aβ production compared with a chimeric APP with a NgCAM cytoplasmic sequence artificially targeted to the axons [82].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“total-surface staining of APP is 66.0 Ϯ 4.0% on the axonal membrane versus 44% on the dendritic membranes”
§ Neurobiology of Disease Differential Release of -Amyloid from Dendrite-Versus Axon-Targeted APP > Polarized distribution of APP in primary hippocampal neuron cultures
Reported 100 · recomputed 110
Citations
Cites
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757 · cited 1×
“…this important issue, we generated constructs that express human APP-695 harboring mutations in the ectodomain that preclude processing by - (K612V; Sisodia, 1992) or - secretases (M596V; Citron et al., 1992), and analyzed the polarity of the expressed protein in transduced hippocampal neurons.”
BackgroundKaech, S., & Banker, G. (2006) · Nature Protocols · doi:10.1038/nprot.2006.356 · Cited by 1,659
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Self-citationSynaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265 · cited 2×
“Synaptic activity increases A release (Kamenetz et al., 2003; Cirrito et al., 2005), and high levels of A inhibit the induction of long-term potentiation (Kamenetz et al., 2003).”
Culturing hippocampal neurons.
TANAKA, H. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.119.163 · Cited by 1,126
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075 · cited 2×
“…by the fact that APP is subject to constitutive processing by both - and -secretase (BACE 1) that leads to shedding of the ectodomain on the plasma membrane (Sisodia, 1992) and endosomal compartments (Koo and Squazzo, 1994; Kinoshita et al., 2003), respectively (for review, see Haass et al., 2012).”
BackgroundSelf-citationBACE1 is the major β-secretase for generation of Aβ peptides by neurons
Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., & Wong, P. C. (2001) · Nature Neuroscience · doi:10.1038/85064 · Cited by 1,064
Evidence that production and release of amyloid beta-protein involves the endocytic pathway
Koo, E. H., & Squazzo, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32449-3 · Cited by 829
Beta-amyloid precursor protein cleavage by a membrane-bound protease.
Sisodia, S. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6075 · Cited by 738
Self-citationPrecursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L., & Price, D. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1561 · Cited by 733
Self-citation
Cited by
Not just amyloid: physiological functions of the amyloid precursor protein family
Müller, U. C., Deller, T., & Korte, M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.29 · Cited by 634
Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies
Polanco, J. C., Li, C., Bodea, L.-G., Martinez-Marmol, R., Meunier, F. A., & Götz, J. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.162 · Cited by 378
β-amyloid Peptides and Amyloid Plaques in Alzheimer's Disease
Gouras, G. K., Olsson, T. T., & Hansson, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0313-y · Cited by 325
Cellular Functions of the Amyloid Precursor Protein from Development to Dementia
van der Kant, R., & Goldstein, L. S. B. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.022 · Cited by 245
Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway
Das, U., Wang, L., Ganguly, A., Saikia, J. M., Wagner, S. L., Koo, E. H., & Roy, S. (2016) · Nature Neuroscience · doi:10.1038/nn.4188 · Cited by 192
Metadata
- Authors
- DeBoer, S. R., Dolios, G., Wang, R., & Sisodia, S. S.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of Chicago (US)
- Corresponding author
- Sisodia, Sangram S.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2014-09-10
- Volume
- 34
- Issue
- 37
- Pages
- 12313-12327
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC4160770
- OpenAlex
- W1967673679
- Semantic Scholar
- ca38ce5a5118fb6d581d247adf469839358e8ed3
- Cited by
- 51
- References
- 40
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 4 · 2014: 1
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- Cure Alzheimer's Fund
- Eisai
- National Institutes of Health
- National Institute on Aging (F30AG034001)
- National Institute of Neurological Disorders and Stroke (P30NS061777)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, amyloid precursor protein, dendrites, axons, Alzheimer's disease, glutamatergic neurotransmission, APP knockout mice, lentiviral transduction, APP processing
- MeSH terms
- Animals, Axons, Cells, Cultured, Dendrites, Female, Male, Tissue Distribution, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Rats, Sprague-Dawley, Presynaptic Terminals, Mice, Knockout, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential Release of β-Amyloid from Dendrite- Versus Axon-Targeted APP. https://app.cochat.ai/papers/10.1523/jneurosci.2255-14.2014
- The paper
- DeBoer, S. R., Dolios, G., Wang, R., & Sisodia, S. S. (2014). Differential Release of β-Amyloid from Dendrite- Versus Axon-Targeted APP. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.2255-14.2014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.